Steve Hopkins

Statistics

Publications

Citations

1.2K

H-Index

Active since

1994

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Southwestern Medical Center

Fondazione IRCCS Istituto Neurologico Carlo Besta

The University of Texas Southwestern Medical Center

Stanford University

Steve Hopkins is an author at Alexion Pharmaceuticals (United States) specializing in anti-acetylcholine receptor antibodies, medicine, and myasthenia gravis pharmacotherapy.

Publications per year

1994–2024

Publications

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Characterization of ganglionic acetylcholine receptor autoantibodies

Steven Vernino, Jon Lindstrom, Steve Hopkins et al. · Journal of Neuroimmunology · 2008 · 82 citations · Full text

Life Sciences, Neurobiology, Neuroscience +12

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Cholinergic Autonomic Dysfunction in Veterans With Gulf War Illness

Robert W. Haley, Elizabeth Charuvastra, William E. Shell et al. · JAMA Neurology · 2012 · 75 citations

Nursing, Internal Medicine, Psychiatry +17

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 8